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Abstract DNA pooling is an efficient method to rapidly
perform genome-wide linkage scans in autosomal reces-
sive diseases in inbred populations where affected indi-
viduals are likely to be homozygous for alleles near the
disease gene locus. We wanted to examine whether this ap-
proach would detect linkage in autosomal dominant (AD)
disorders where affected individuals may share one allele
identical by descent at loci tightly linked to the disease.
Two large outbred pedigrees in which the AD diseases fa-
milial venous malformation (FVM) and hereditary hemor-
rhagic telangiectasia (HHT1), linked to 9p and 9q, respec-
tively, were investigated. Separate pools of DNA from af-
fected (n = 21 for FVM and 17 for HHT1) and unaffected
family members (n = 9 FVM and HHT1), and 25 unre-
lated population controls were established. Polymorphic
markers spanning chromosome 9 at approximately 13.5-
cM intervals were amplified using standard PCR. Allele
quantitation was performed with a fluorimager. Visual in-
spection of allele intensities and frequency distributions
suggested a shift in frequency of the most common allele
in the affecteds lane when compared to control lanes for
markers within 30 cM of the FVM and HHT1 loci. These
subjective assessments were confirmed statistically by test-
ing for the difference between two proportions (one-sided;
P ≤ 0.05). When using population controls, the true-posi-
tive rates for FVM and HHT1 were 5/5 and 2/5 markers,
respectively. False-positive rates for FVM and HHT1
were 3/9 and 2/9, respectively. In both AD diseases inves-
tigated, quantitative DNA pooling detected shifts in allele
frequency, thus identifying areas of known linkage in
most cases. The utility of this technique depends on the
size of the pedigree, frequency of the disease-associated
allele in the population, and the choice of appropriate con-
trols. Although the false-positive rate appears to be high,
this approach still serves to reduce the amount of overall
genotyping by about 60%. DNA pooling merits further in-
vestigation as a potential strategy in increasing the effi-
ciency of genomic linkage scans.
Introduction
DNA pooling (Smith 1953; Lander and Botstein 1987;
Sheffield et al. 1995), has been shown to be a powerful
and efficient method to rapidly perform genome-wide
linkage scans in autosomal recessive diseases in inbred
populations where affected individuals are likely to be ho-
mozygous for alleles at loci surrounding the disease gene
(Ben Hamida et al. 1993; Pollak et al. 1993; Sheffield et
al. 1994; Carmi et al. 1995). This strategy exploits the fact
that affected individuals in inbred families share a chro-
mosomal region inherited from a common ancestor sur-
rounding the disease locus. Traditionally, genotype results
are generated for individual DNA samples using a given
marker or markers. In the DNA pooling strategy, DNA
from multiple affected and unaffected individuals from
each family as well as population controls are pooled in
separate lanes and simultaneously amplified by PCR with
a given marker. Markers linked to (LOD score > 3.0) and
in association with a disease gene will show loss of het-
erozygosity and hence a different pattern of alleles from
appropriate control groups. Unlinked markers should
demonstrates an allele distribution that is similar to con-
trol lanes. This strategy considerably reduces the number
of PCR reactions and gel lanes needed to screen a marker
while conducting a genome-wide or candidate gene scan.
We investigated whether this approach would detect link-
age in autosomal dominant (AD) disorders, as suggested
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by Kanis et al. (1995), where affected individuals within a
family may share one allele identical by descent at loci
tightly linked to the disease.
Patiens and methods
Hereditary hemorrhagic telangiectasia (HHT1) and familial ve-
nous malformation (FVM) were selected for study because we had
access to large outbred AD pedigrees that are linked to opposite
arms of chromosome 9 (McDonald et al. 1994; Gallione et al. 1995),
thus permitting a single chromosome scan as a strategy for a lim-
ited simulated genome scan. For the pooling experiments, DNA
was quantitated rapidly with a Molecular Dynamics fluorimage SI
using a picogreen protocol supplied by the company. Separate pools
of DNA from affected (n = 21 for FVM and 17 for HHT1) and unaf-
fected (n = 9 for both FVM and HHT1) family members, and 25 un-
related population controls were established by combining equal
amounts of DNA from each individual. Phenotypically unaffected
relatives were selected in the line of descent to act as a control within
the family. Individuals with uncertain phenotype were excluded
from this group, assuming that some individuals might be non-pene-
trant gene carriers. The population control group consisted of ethni-
cally and geographically matched individuals who were randomly
selected healthy spouses from other pedigrees in our laboratory.
Polymorphic tetranucleotide markers were chosen to span chro-
mosome 9 (Fig.1). These markers were noted in preliminary stud-
ies to produce much less stutter artifacts than dinucleotide mark-
ers, thus making allele identification and quantitation easier. In 
order to fill a gap towards the telomeric end of chromosome 9q,
where tetranucleotide markers are not represented, three dinucleo-
tide markers were also selected as part of the chromosome scan. In
total, 14 markers were chosen, spaced at an average interval of ap-
proximately 13.5 cM. Markers were amplified using standard PCR
(Carmi et al. 1995) with 50 ng of total DNA from each pool.
Allele quantitation was performed with a Molecular Dynamics
fluorimager SI, which generated frequency distribution curves. Al-
lele quantitation was performed by determining the area under
each allele peak and dividing this area by the total area under all
allele peaks. The frequency of the most common allele in the af-
fecteds lane was then compared to the frequency of that same al-
lele in unaffected and population control lanes by testing for the
difference between two proportions (one-sided). A significance
level of 0.05 was utilized. Since this approach is intended to be uti-
lized as an initial screening procedure, no corrections for multiple
comparisons are necessary.
Visual inspection was carried out in the following manner. The
allele that was most intense in the affecteds lane was identified
(since this is most likely to be the linked allele) and then compared
to the relative intensity of the same allele in the adjacent unaffect-
eds and population control lanes (Fig.2a). Next, the allele quanti-
tation plot obtained via fluorimager analysis of the gel was exam-
ined (Fig.2b). Once again, the affecteds lane was examined first,
looking for the tallest peak. A comparison of the height for the
same allele in adjacent control lanes allows one to determine if the
difference looks significant.
In order to generate LOD scores, we utilized MLINK at θ val-
ues of 0, 5, 10, 15, 20, 30, and 40. The maximum LOD score was
obtained by inspection of the profile of linkage and examining 1%
intervals between the region where it appeared the maximum
would be, i.e., if the profile looked as though the maximum was
between 10 and 15, LOD scores were calculated at θ values of 11,
12, 13, and 14. If the maximum appeared to fall beyond 20 cM, the
maximum LOD score at the nearest θ value of 20, 30 or 40 was re-
ported.
Results
Visual inspection of gels and allele frequency distribu-
tions suggested a shift in the frequency of the most com-
mon allele in the affecteds lane when compared to popu-
lation control lanes for most of the markers within 30 cM
of the FVM and HHT1 loci. Statistical significance (P ≤
0.05) was found for all markers within 30 cM of the FVM
locus (D9S925, D9S319, D9S1124, D9S1122, D9S303)
and for two markers within 30 cM of the HHT1 locus
(D9S930, D9S158), yielding true-positive rates of 5/5 and
2/5, respectively. For example, marker D9S925 is tightly
linked to FVM, and this is apparent by visual inspection
of the gel (Fig. 2a) as well as the allele frequency distrib-
ution (Fig.2b) when comparing allele I in the affecteds
versus unaffected and population control lanes. These re-
sults were confirmed by statistical analysis comparing the
frequency of this allele in the affecteds and control lanes
(Table 1). One marker linked to the HHT1 locus (D9S60)
did not demonstrate an association because of an ancestral
recombination which led to two different alleles segregat-
ing in separate portions of the pedigree. The marker
D9S302, which is within 30 cM of HHT1, did not give
consistent PCR products despite multiple PCRs and hence
allele frequencies may not be accurate.
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Fig.1 Map of chromosome 9 demonstrating location of markers
used in this study (Murray et al. 1994) relative to the location of
the genes for familial vascular malformation (FVM; Vikkula et al.
1996) and hereditary hemorrhagic telangiectasia (HHT1; McAllis-





Some unlinked markers also demonstrated false posi-
tives (defined as P value ≤ 0.05 outside 30 cM of the 
disease locus). Specifically, using population controls,
D9S2624, D9S318, and D9S930 yielded significant P val-
ues for a false-positive rate of 3/9 in FVM. In HHT1, the
false-positive rate was 2/9 (D9S319 and D9S1124). Uti-
lizing the unaffected family members as controls, FVM
generated a lower true-positive rate of 3/5 and a false-pos-
itive rate of 2/9. Analysis of the HHT1 data utilizing un-
affected family members as controls yielded a true-posi-
tive rate of 0/5 and false-positive rate of 1/9.
Discussion
DNA pooling offers an efficient strategy to simplify ge-
nome-wide screens when looking for linkage in large in-
bred autosomal recessive pedigrees. This strategy has also
been applied successfully to a rare recessive disease in the
face of heterogeneity (Gschwend et al. 1996). The authors
caution, however, that a sufficiently dense genetic map is
necessary for this approach to be successful when hetero-
geneity is present, and any false positives must be fol-
lowed up by typing further markers in the region. DNA
pooling has also been suggested as a strategy applicable to
mapping genes in AD disorders segregating in large kin-
dreds, and in polygenic disorders (Kanis et al. 1995). Re-
cently, a susceptibility gene, inherited as AD with incom-
plete penetrance, was identified for atrioventricular canal
defects using a combination of DNA pooling and shared
segment analysis (Sheffield et al. 1997). 
We investigated the DNA pooling approach in AD dis-
orders where large outbred pedigrees are available. This
strategy assumes a relatively low frequency of the linked
allele in the population in order that a difference can be
detected in affecteds versus control lanes. An allele with a
frequency approaching 50% in the population may closely
approximate a linked allele (i.e., appear as the most intense
band) within a family. Two large pedigrees (McDonald et
al. 1994, Gallione et al. 1995), one with FVM and the other
with HHT1 linked to 9p and 9q, respectively, were studied
using DNA pooling and polymorphic markers spanning
chromosome 9 in order to simulate a partial genome scan.
We were able to detect, by visual inspection, a shift in al-
210
Locus FVM frequency of allele Con- P HHT1 frequency of allele Con- P FVM HHT1
trols trols z (θ̂), (θ̂) z (θ̂), (θ̂)
Affect- Unaf- P Affec- Unaf- P
eds fecteds teds fecteds
D9S917 0.81 0.85 NC 0.82 NC 0.58 0.50 0.398 0.82 NC 0.46 (0.20) 0.00 (0.40)
D9S2624 0.48 0.18 0.029 0.04 < 0.001 0.52 0.20 0.026 0.46 0.375 4.59 (0.04) 2.34 (0.10)
D9S925a 0.51 0.14 0.008 0.14 < 0.001 0.40 0.30 0.341 0.29 0.203 8.66 (0.00) 0.83 (0.15)
D9S319a 0.84 0.64 0.085 0.36 < 0.001 0.60 0.48 0.296 0.36 0.026 4.38 (0.00) 0.83 (0.20)
D9S1124a 0.56 0.27 0.037 0.22 0.001 0.43 0.43 0.384 0.20 0.021 3.49 (0.07) 1.11 (0.13)
D9S1122a 0.52 0.26 0.057 0.11 < 0.001 0.51 0.28 0.097 0.38 0.169 2.18 (0.10) –0.02 (0.40)
D9S303a 0.36 NO < 0.001 NO < 0.001 0.29 0.24 0.477 0.42 NC 0.87 (0.20) 0.12 (0.30)
D9S318 0.78 0.40 0.005 0.53 < 0.001 0.41 0.76 NC 0.53 NC 1.30 (0.11) 0.96 (0.20)
D9S300 0.42 0.30 0.279 0.33 0.09 0.38 0.39 NC 0.33 0.405 1.11 (0.20) 0.61 (0.20)
D9S930b 0.48 0.24 0.074 0.25 0.019 0.53 0.50 0.466 0.25 0.008 0.34 (0.20) 0.77 (0.15)
D9S302b 0.34 0.39 NC 0.19 0.081 0.23 0.16 0.407 0.24 NC 0.46 (0.30) 1.29 (0.14)
D9S60b 0.18 0.16 0.427 0.20 NC 0.22 0.17 0.474 0.15 0.297 – 5.08 (0.03)
ABLb 0.29 0.27 0.438 0.33 NC 0.43 0.23 0.130 0.33 0.241 – 5.52 (0.00)
D9S158b 0.32 0.29 0.470 0.23 0.232 0.28 0.08 0.092 0.33 0.016 –0.04 (0.40) 2.46 (0.11)
Number of
chromo-
somes 42 18 50 34 18 50
a Markers within 30 cM of the FVM locus
b Markers within 30 cM of the HHT1 locus
Table 1 Frequency of the most common allele in familial venous
malformation (FVM) and hereditary hemorrhagic telangiectasia
(HHT1) affecteds lane in comparison to the frequency of the same
allele in unaffected and population control lanes. (NO Allele not
observed, NC not calculated since affecteds allele frequency was
less than the frequency in the comparison group)
Fig.2 a Gel image from a fluorimager demonstrating allele inten-
sities for FVM unaffected, affected, and population control pools
with tetranucleotide marker D9S925. A clear difference is seen with
the linked allele (I) which is much more intense in the affecteds
lane when compared to control lanes. b Allele frequency distribu-
tions of the same marker shown in a. Area under each peak was
quantitated by the fluoroimager to arrive at an estimate of the fre-
quency of each allele. A striking difference can be seen in the ap-
pearance of the linked allele (I) in affecteds when compared to un-
affected and population control plots. c Gel image for the unlinked
marker D9S318 in FVM pooled samples. Allele C is the most in-
tense in the affecteds and relatively more intense than in the popu-
lation and unaffected controls. This is an example of a false-posi-
tive marker (i.e., appears to be linked by visual inspection and quan-
titation but the LOD score is < +3.0). d Allele frequency distribu-
tion for the marker D9S318 shown in c. e Gel image for the linked
marker D9S60 in HHT1 pooled samples. This is an example of a
false-negative result. An ancestral crossover is present and multi-
ple, intense bands are visible in the affecteds lane, making it diffi-
cult to decide which is the most intense allele. Stutter bands from
each allele also complicate visual inspection. f Allele frequency
distribution for marker D9S60 shown in e. Allele quantitation is
extremely difficult due to stutter bands overlapping with alleles
F
lele frequencies in the affecteds lane when compared to
allele frequencies in the unaffected and population control
lanes for all markers linked to FVM and for some markers
linked to HHT1. We confirmed these differences statisti-
cally and were able to show that 5/5 and 2/5 markers with-
in 30 cM of the FVM and HHT1 loci, respectively, dem-
onstrated a statistically significant difference when popu-
lation controls were utilized. One marker (D9S60) did not
demonstrate an association because of an ancestral recom-
bination which was previously demonstrated by haplotype
analysis (McDonald et al. 1994). It is also important to
note that 4/4 of the markers linked to FVM (LOD score >
3.0) were detected by the pooling method as being signif-
icant, while none (0/2) of the markers linked to  HHT1
were detected by this method (D9S60 and ABL, both din-
ucleotide repeat markers). Unfortunately, at the time of
the study, no tetranucleotide markers were available in the
HHT1 region and we therefore utilized dinucleotide mark-
ers which made both the visual inspection and allele quan-
titation far more complicated due to the presence of su-
perimposed stutter bands. We also compared allele fre-
quencies in affecteds with genotypically unaffected indi-
viduals within the same family and obtained a true-posi-
tive rate of 3/5 and 0/5 for FVM and HHT1, respectively.
Although in theory the comparison of allele frequencies in
affected individuals to frequencies in unaffected family
members is valid when the penetrance is high, in our pedi-
grees the power to detect significant differences was lim-
ited by the available sample size; furthermore, when the
frequency of the disease-associated allele is common in
the population, the probability that a mating is uninforma-
tive due to parental homozygosity is increased. Similarly,
an identical difficulty will arise if the disease-associated
allele is common in the pedigree by chance.
The choice of controls, as with any association study,
is an important one. Unrelated controls should be matched
at least geographically and ethnically, as in this study, since
allele frequencies are known to differ in various popula-
tions. In general we prefer to use multiple types of con-
trols, but place most weight on the “population controls”
rather than “unaffected” family members. This is because
in many cases the penetrance of the disease may not be
high and hence disease status of older unaffected individ-
uals may be uncertain. This problem, however, is not
unique to the pooling strategy, and also plagues classical
linkage analysis. In linkage, however, one can create pen-
etrance classes which allow weighting of the contribution
of the unaffecteds according to their age and likelihood of
being correctly diagnosed. With pooling, this weighting
cannot be taken into account, and therefore pooling is
worse than linkage for analysis of diseases with low or
age-dependent penetrance. Population controls also have
the advantage of pooling more individuals and giving a
more accurate estimate of the true allele frequencies but
have the drawback of misrepresenting the allele distribu-
tion in the families. Where available, spousal controls may
be helpful as in most cases spouses belong to the same
population as the family under study. In most situations,
however, spouses are limited in number (only one spouse
per sibship) and may not be available for sampling.
Although DNA pooling is capable of detecting linked
regions in our AD families, a number of other caveats,
similar to those in any association study, need to be men-
tioned. First, our families represent large, multigenerational
pedigrees, representing an ideal situation for pooling. The
utility of pooling in multiple small families has not been
established. In the latter situation, locus heterogeneity and/
or lack of linkage disequilibrium may dilute the strength
of the pooling approach. Secondly, we obtained a false-
positive rate of 22–33% in our scan of chromosome 9.
Relatively few markers were used in comparison to a ge-
nome-wide scan, and hence the false-positive rate we have
obtained may not be entirely accurate. Recently, Sheffield
et al. (1997) used 360 markers in a genome-wide scan to
study a large family with a complex congenital heart de-
fect that appeared to demonstrate an AD inheritance pat-
tern. Twenty markers (6% false-positive rate) demonstrat-
ed a predominance of a shared allele in the affected pool
by visual inspection when compared to control pools of
unaffected individuals. The number of “interesting” mark-
ers was further reduced to five regions by limiting inter-
esting regions to clusters of two or more positive markers.
One of these regions subsequently demonstrated linkage.
Hence, a combination of strategies, such as DNA pooling
and shared segment analysis, may prove fruitful in future
studies involving AD and/or complex disorders. Further
studies involving screening a large portion of or the entire
genome with markers in various AD disorders will be
needed before it is clear what threshold one should set to
determine what constitutes a positive marker, and before a
clearer idea of the false-positive rate with the DNA pool-
ing approach can be obtained.
As always, the acceptable type 1 error rates and power
to detect a true association are intimately intertwined. In
general, requiring a more stringent level of threshold for
significance will tend to reduce the type I error rate but
may lead to the failure to identify the true region of inter-
est. In our families, reducing the threshold for signifi-
cance from 0.05 to 0.02 did not alter the frequency of the
true positives in FVM and HHT1 when population con-
trols are used; however, the two false positives for HHT1
are excluded. Our preference is to suggest a less stringent
significance level, since a false-negative result could un-
dermine the entire linkage effort.
Several technical lessons have emerged from our study
that are pertinent to future DNA pooling experiments. Ac-
curate DNA quantitation is important so that pools with
equal amounts of DNA from each individual can be es-
tablished in order to permit the DNA sample from each
patient equal opportunity for amplification. Tetranucleo-
tide markers are superb for quantitation since they pro-
duce very little in the way of stutter artefact. Dinucleo-
tides are much more difficult to quantitate, although one
could incorporate a stutter correction algorithm (LeDuc et
al. 1995; Perlin et al. 1995). We believe that quantitation
of allele frequencies is important in the context of pooling
for dominant disorders. Visual inspection is helpful but
can be difficult due to the complex pattern of alleles in
each lane (in contrast to recessive disorders where one is
looking for loss of heterozygosity, i.e., a collapse of the
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allele pattern to one intense allele band). For dominant
disorders, one has first to pick out the most intense allele
in the affecteds lane (difficult if two alleles are almost as
intense) and then compare this relative intensity to the rel-
ative intensity of the same allele in control lances (see
Fig.2a). Differences are much more easily appreciated
with quantitation rather than visual inspection. For exam-
ple, in Fig.2c, allele C for marker D9S318 is clearly the
most intense in the affecteds lane, yet by visual inspection
appears to be only slightly more intense than the same al-
lele in the population control lane. With quantitation,
however, it is easily apparent that the frequency of the al-
leles in affecteds (78%) is quite different from that in pop-
ulation and family control lanes (53% and 40%, respec-
tively). A fluorescent system is ideal for quantitation since
it offers a linear scale over many log units of fluorescence.
We have tried densitometry with conventional autoradi-
ographs and found it to be satisfactory, but only if the film
threshold has not been exceeded (i.e., overexposure has
not occurred). In addition, studies have shown that the al-
lele frequencies obtained through pooling and fluorescent
analysis are very close to frequencies obtained if individ-
uals have been genotyped separately (Pacek et al. 1993;
Darvasi et al. 1994; LeDuc et al. 1995). Differential allele
amplification, a potentially important theoretical concern,
does not appear to present a problem in practice (Kanis et
al. 1995).
To summarize, in both AD diseases investigated, quan-
titative DNA pooling detected shifts in allele frequency of
most linked markers, thus identifying the areas of known
linkage. The utility of this technique depends on the size
of the pedigree, frequency of the disease-associated allele
in the population, and choice of appropriate controls. Al-
though the false-positive rate appears to be high, this ap-
proach may serve to reduce the amount of overall geno-
typing by about 60%. DNA pooling merits further inves-
tigation as a potential strategy in increasing the efficiency
of genomic linkage scans.
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